Epidemiology of giant-cell arteritis

Cleveland Clinic Journal of Medicine

Volumn 69, Issue SUPPL. 2, 2002, Pages

  Hunder, Gene G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; ETHNOLOGY; GEOGRAPHIC DISTRIBUTION; GIANT CELL ARTERITIS; HUMAN; INCIDENCE; AGED; COMMUNICABLE DISEASE; DEMOGRAPHY; EUROPE; FEMALE; ISRAEL; MALE; MIDDLE AGED; PERIODICITY; REVIEW; RISK FACTOR; TEMPORAL ARTERITIS; TREATMENT OUTCOME; UNITED STATES;

AGED; COMMUNICABLE DISEASES; EUROPE; FEMALE; HUMANS; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; MINNESOTA; PERIODICITY; RESIDENCE CHARACTERISTICS; RISK FACTORS; TEMPORAL ARTERITIS; TREATMENT OUTCOME;

EID: 0036051576     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.suppl_2.sii79     Document Type: Conference Paper

References (32)

1. Hutchinson J. Disease of the arteries. Arch Surg (London) 1890; 1:323.
2. Horton BT, Magath BT, Brown GE. An undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clin 1932; 7:700.
3. Horton BT, Magath BT, Brown GE. Arteritis of the temporal vessels: A previously undescribed form. Arch Intern Med 1934:400-409.
4. Doran MF, Crowson CS, O'Fallon WM, et al. Trends in the incidence of polymyalgia rheumatica over a 30-year period in Olmsted County, Minnesota. Submitted for publication.
5. Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 2000; 27:2624-2627.
6. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 1997; 24:1739-1743.
7. Baldursson P, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994; 37:1007-1012.
8. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 1999; 38:1208-1212.
9. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumonias infection. J Rheumatol 1996; 23:112-119.
10. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 1992; 19:273-276.
11. Rajala SA, Ahvenainen JE, Mattila KJ, Saami MI. Incidence and survival rate in cases of biopsy-proven temporal arteritis. Scand J Rheumatol 1993; 22:289-291.
12. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, et al. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001; 60:367-371.
13. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 1994; 33:938-941.
14. Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991; 34:351-356.
15. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978; 88:162-167.
16. Machado EBV, Michet CJ, Ballard DJ, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988; 31:745-749.
17. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123:192-194.
18. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of giant cell arteritis. Manuscript in preparation.
19. Smith CA, Fidler WJ, Finals RS. The epidemiology of giant cell arteritis: report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983; 26:1214-1219.
20. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994; 37:514-520.
21. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995; 38:369-373.
22. Gabriel SE, Espy M, Erdman DD, et al. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 1999; 42:1255-1258.
23. Reinhold-Keller E, Zeidler A, Gutfleisch J, et al. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000; 39:1396-1402.
24. Duhaut P, Bosshard S, Calvet A, et al. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes. J Rheumatol 1999; 26:361-369.
25. Proven A, Orces C, Hunder GG, et al. Manuscript in preparation.
26. Casselli RJ, Hunder GG. Giant cell (temporal) arteritis. Neurol Clin 1997; 15:893-902.
27. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population based study. Ann Intern Med 1995; 122:502-507.
28. Bisgard C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis. J Intern Med 1991; 230:119-123.
29. Gabriel SE, Sunku J, Salvarani C, et al. Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997; 40:1873-1878.
30. Matteson E, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology classification cohort. Am J Med 1997; 100:193-196.
31. Gonzalez Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain is associated with low long-term mortality. J Rheumatol 1997; 24:2171-2176.
32. Hachulla E, Boivin V, Paturel-Michon V, et al. Prognostic factors and long-term evaluation in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol 2001; 19:171-176.